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The  occurrence  in  bacteria  of  substances  possessing  a  close  serological 
relationship  to  A,  B,  and H(O)  erythrocyte agglutinogens was  first  shown 
unequivocally by  Schiff (1)  for  one  strain  of ShigeUa skigae.  He  grew  this 
bacterium on a  chemically fully defined medium free of demonstrable blood 
group activity. Other Gram-negative bacteria have been reported by Japanese 
and German workers to be related serologically to human blood groups A, B, and 
H(O) (of. references 2, 3), but the preexistence of blood group active substances 
in the growth medium used by these investigators is almost certain. More recent 
studies in this laboratory (4) indicated that several different bacteria grown in 
a  chemically fully defined medium exhibited  specific  blood group  A,  B,  or 
H(O)  activity.  A  more  extensive  study of  this  subject  appeared  desirable 
because of the close contact between Gram-negative bacteria and human beings 
and the possible relation of anti-A and anti-B isohemagglutinin formation to 
these bacteria.  Such an investigation is especially indicated since it has been 
shown that anti-A and anti-B heterohemagglutiuins may be induced by bacteria 
(5, 6) and that "hyperimmune"  blood group agglutinins may be instrumental 
in the inhibition (5) and even killing (7) of blood group active bacteria. 
A  correlation between serological specificity and chemistry of blood group 
active bacteria may further the understanding of the chemical basis for  the 
specificity of human blood group substances. 
The  present paper  reports  data obtained during the past  7 years on the 
blood group activity of 282  Gram-negative bacteria. An attempt is made to 
relate the blood group activity of some of these bacteria with their content of 
those monosacchaxides which  are  also  building-stones of human A,  B,  and 
H(O) blood group mucoids. The data to be presented emphasize the presence 
* This study was supported by the National Science  Foundation Grant G-10905 and part 
of the work on infants by the National Institutes  of  Health  Grant  A-2671. Dr.  R.  F. 
Norris kindly permitted use of routine facilities  of the Bacteriology  Section  of the Pepper 
Laboratory. 
:~ Established Investigator of the American  Heart Association. 
1077 1078  BLOOD  GROUP  ACTIVE  BACTERIA 
of  similar  serological  and  chemical  structures  in  groups  as  widely  separated 
phylogenetically as bacteria and man. 
Materials and Methods 
Bacteria.--Gram-negative  bacteria were isolated by  standard  bacteriological procedures 
from patients' specimens sent for routine analysis to the University Hospital's Bacteriological 
Laboratory.  A  random selection was  desired,  but  over the  past  1~/~ years  Gram-negative 
organisms isolated from the blood of patients have been collected predominantly. Such cul- 
tures occurred as less than 0.3 per cent of all routine specimens. Furthermore, attempts were 
made to increase the number of strains tested in those genera from which we had isolated 
too few organisms to be representative. 
Many blood group active strains were sent to Dr. P.  R. Edwards and Dr. W. H.  Ewing, 
Communicable Disease Center, Chamblee, Georgia, to check our identification as to species 
and serotype.  In addition, bacterial cultures of known species and serotype were  obtained 
from  Dr.  Edwards,  the American Type  Culture  Collection in  Washington,  D.  C.,  Dr.  E. 
Thai, Stockholm, and other laboratories. Strains of the genera Salmonella, Shigdla, Arizona, 
and Pasteurella were  obtained predominantly from outside sources.  Most of  the organisms 
studied were Enterobacteriaceae which were classified  according to Kanffmann (8), (with the 
provision that no attempt was made to identify the genus Cloaca as a  separate entity), but 
strains of  the  Pseudomonadaceae,  Brucellaceae,  and  Achromobacteraceae,  as  well  as  one 
strain of Bacterium anitratum were also tested. 
Preparation of Bacteria.--The  smoothness and purity of all cultures were  confirmed im- 
mediately before use. Test tubes containing 10 ml. of tryptose phosphate broth were inocu- 
lated from the fresh agar slants of the organism to be studied. Eight successive subcultures 
were then made with a  loop (diameter 3.5 ram.) into 10 ml. of a  fully defined vitamin-and 
amino acid-free glucose ammonium chloride medium, shown to be devoid of blood group A, 
B,  and H(O)  active substances  (4).  When an occasional strain did not grow in  this basal 
medium, yeast extract (bacto difco)  was added in a  final concentration of 0.1 per cent. This 
autolysate did not show any blood group A, B, or H(O) activity when tested at a concentra- 
tion of 20 mg./ml, or less. Each culture was incubated for 16 to 24 hours at 37°C.  before the 
subsequent transfer. A final subculture was made into two 50 ml. tubes of the same medium. 
The  bacteria were  grown  approximately 40 hours,  then  harvested  by  centrifugation.  The 
sedimented cells were resuspended in distilled water and heated on a  boiling water bath for 
2~  hours to  remove the possible masking effect of heat-labile antigens (8).  The final con- 
centration of bacteria was adjusted to a  dry weight of 0.5 to  1.5 per cent. 
Solutions.--The  diluent  and  the  erythrocyte-suspending solution in  all  tests  were  0.85 
per cent saline, containing 0.025  ~  phosphate buffer, pH  7.2. 
Erythrocytes.--Human A~, A~, B, and H(O) erythrocytes, stored for no more than 2 weeks 
in one-third volume  "anticoagulant acid citrate dextrose"  solution  (1.47  per  dent  glucose, 
1.32 per cent sodium citrate, 0.44 per cent citric acid) at 1-3°C.,  were employed. They were 
obtained from 2 donors for each group. Erythrocytes were added in a 0.5 per cent suspension 
after 3 saline washings. 
Antlsera.--Human  anti-A and anti-B sera, both "natural" and immune, were employed. 
The latter were prepared by immunization of volunteers with purified blood group substances 
of hog or horse origin. Eel serum containing potent anti-H(O)  agglutinins, after absorption 
with human A~B erythrocytes, was used in the agglutination of group O erythrocytes. 
A  limited amount of human anti-H  (Helen  Porcano)  and  rabbit anti-H(O)  agglutinins 
(prepared by injecting human H(O) mucoid conjugated with the protein component of Shiga 
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Serologival Procedures.--Blood  group  activity was  measured with the hemaggiutination 
inhibition test as previously described  (9, 4).  This assay was used as a  routine, instead of 
direct bacterial agglutination or  absorption of  sera,  because  of  its  higher sensitivity and 
greater economy. On occasion, these latter procedures as well as animal immlmlzation have 
been used as is discussed below. All reagents were employed in 0.1 ml. volume. In brief, the 
testing procedure was as follows: Twofold serial dilutions of bacterial suspensions were made 
using a  different 0.1 ml. serological pipette for each tube in a  titration series. The titrated 
suspensions were shaken and incubated with 4 to 8 minimum hemagglutinating doses of anti- 
serum for 2 hours at room temperature (22-26°C.). The appropriate erythrocytes were then 
added, and the test read microscopically after a further 1 to 2 hours' incubation period at room 
temperature. Each titration series included controls consisting of a serum standard, diluted to 
4 to 8  minimum hemaggiutinating doses and then tit.rated in twofold geometrical dilutions, 
and a  saline suspension of the appropriate erythrocytes. L-Fucose was included as standard 
in the assays with eel serum. Active materials were tested three or more times. 
Bacterial suspensions which did not  inhibit at concentrations of 2.5 mg./ml, or less were 
considered to be inactive. Under the conditions of the present experiments, specificity  and 
reproducibility were found to be wanting at concentrations of more than S mg./ml, of inhibitor 
or less than 4 minimum hemagglutinating doses of serum. Activities are expressed in terms of 
dilution of the inhibiting material before addition of serum and erythrocyte suspension.  Final 
concentrations of inhibitor are obtained by dividing the given values by 3. 
Numerous bacteria have also been tested for their ability to inhibit erythrocyte  agglutina- 
tion by anti-D  (Rho), anti-M, and anti-N agglutinins. Agglutinins and red cells used were 
described previously  (10).  As anti-N reagent,  an extract of  Vicia  graminea seeds grown in 
this laboratory was used exclusively. 
RESULTS 
Table I lists bacteria tested for A1, B, and H(O) blood group activity. Almost 
50 per cent of the strains examined inhibited anti-human  blood group A, B, 
H(O)  agglutinins  at  concentrations  considered to  indicate  activity. Table I 
also shows that bacteria with only 1 specificity far outnumber those with 2 or 
all 3 blood group activities. The activities of a given strain often varied some- 
what quantitatively for different batches but not qualitatively. 
The most commonly observed blood group specificities were H(O) (against 
eel serum) and B, either alone or in combination. They predominated in all 
genera which contained active strains. Thirty-one additional strains of E. coli 
not listed in the tables were tested for A activity exclusively.  Only 2 of these 
strains showed A activity (low). 
Tables II  and III  divide the  active  bacteria  into  2  arbitrary  classes,  the 
10 per cent which were found to be highly active (Table II) and those bacteria 
(about 38 per cent) of moderate to low activity (Table III). The serotypc is 
given whenever it has been determined.  Inactive bacteria of known serotype 
are listed in Table IV. 
As Table II shows, the highest activities were observed among the B specific 
bacteria. Different serotypes in 6 different genera completely inhibit 4 hemag- 
glutinating doses at concentrations of between 0.5 to 10 #g. of added bacterial 
suspension; i.e., about 2 to 35 ttg./ml, final concentration. Although  in general 1080  BLOOD  GROUP  ACTIVE  BACTERIA 
somewhat  less  active,  6  different  serotypes  which  inhibited  completely  at 
concentrations at or below the 35 #g./ml. final concentration level were found 
among the  H(O)  specific  bacteria.  None of the  A  active  species  was  active 
at this low concentration. 
Twenty strains  of E.  coli  Os6 were  tested,  1 with unknown K  antigen;  16 
had the E. coli B  antigen 7, one Bg, and 2 had no K  antigen.  One E.  coli Os6 
without K antigen was isolated from the blood of a patient. Two cultures of E. 
coli Os~:B7 were grown by us from the stools of diarrheic infants and  1 from 
TABLE I 
Dqstrgbution of Blood Group Activity among Bacteria Tested 
Genus 
Escheriehia 
~almondla 
Arizona 
Klebsiella 
~itrobacter 
Pasteurella 
Proteus 
Pseudomonas 
~erratia 
Alcaligenes 
~higella 
EI  errellea 
Strains 
tested* 
135 
19 
3 
42 
24 
8 
20 
15 
2 
8 
5 
1 
282 
One  activity 
AI  B  H(O) 
8  18  22 
1  2  9 
0  1  1 
2  6  4 
2  2  2 
0  1  0 
0  6  2 
1  1  2 
0  0  2 
0  0  0 
0  0  0 
0  1  0 
14  38  44 
AtBH(O) 
6 
0 
I  o 
3 
0 
0 
0 
0 
0 
0 
0 
0 
* The possibility of having listed the same orgamsm isolated 
Several activities 
BH(O) [ 
-i 
4  71 
o  i  6 
1[  o 
5  20 
3  L  11 
2]  5 
1  11 
0  [  10 
o  i  o 
1  6 
o  i  5 
0  0 
6  9  17  145 
AIB  AIH(O) 
3  3 
0i  i 
o  i  o 
1  1 
2i  2 
0~  0  I 
0  0 
Oi  1 
0  0 
0  1 
0  0 
0  0 
i 
Inactive 
from different patients has 
been excluded only in those cases in which the serotype has been determined. 
the stool of a  patient  with hemolytic anemia.  All  strains had similar  B  and, 
occasionally, low H(O)  activity; however,  the  single  strain  with  B9  antigen 
possessed  somewhat higher H(O)  activity. 
The most highly H(O)  active bacterium found was E.  coli  01~.  Among 2 
strains  of g.  coli 03,  one  (13030)  was of significant H(O)  activity, while  the 
other (O2:K1) was inactive (Tables II and IV). 
Three different strains of E. coli 0111 showed low B  and H(O) activity. 
Nine  strains  of S.  poona,  5  strains  of S.  grumpensis,  and  1 strain  each  of 
S.  atlanta  and S.  worthington  were  tested  (Tables  II and  III); all  strains  of 
these serotypes exhibited quantitatively and qualitatively identical activities. 
All  these  serotypes share  O  antigen  13.  There  was no difference in  activity 
among those serotypes which contained either  O  antigen  22 or 23  besides  O TABLE  II 
Bacteria with High Blood Group Activity 
Bacterium 
n.  COil 
13030 
Edwards, L. 
20 strains 
8399 
Ivey 
Hunter 
SALMONELLA 
poona (9 strains) 
grumpensis (5 strains) 
atlanta 
berkeley 
ARIZONA 
KLEBSIELLA~ 
Scott (Ca484) 
4682 
1598; 1610 
CITROBACTER 
13286 
755 
PROTEUS 
m~abil~ (Ca 437) 
vulgar~ (Ca 439) 
9554 
PSEUDOMONAS 
761 
741 
SERRATIA 
marcescens (airborne) 
HERRELLEA 
Bact. anitratum (3577) 
O-antigen 
](when known) 
86 
127 
128 
13,22 
13,23 
13,23 
43 
9 
21 
10 
63 
Minimum amount of boiled bacteria giving 
complete hemagglutination inhibition* 
mg./ml,  reg.~mr. 
n.a.  n.a. 
0.3  1.2 
n.a.  0.005-0.1 
n,a. 
n.a. 
n.a. 
0.3 
0.3 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
0.3-0.6 
n.a. 
1.2 
n,a° 
n.a. 
n.a. 
0.1 
n.a. 
0.02-0.08 
n.a. 
n.a. 
0.6 
n.a. 
2.5 
0.3-1.2 
n.a. 
0.3 
n.a. 
n.a. 
n.a. 
n.a. 
0.3 
n.a, 
0.3 
0.i 
n.a. 
0. I 
n.a. 
n.a. 
0.1-0.2 
0.05 
0.1-1.2 
n.a. 
n,a. 
n.a. 
0.1  n.a. 
H(O) 
rag.lint. 
0.3-2.5 
2.5 
0.6--4-2.5 
0.3-1.2 
0.04-0.1 
n.a. 
n.a. 
0.6 
0. I 
0.1 
0.1 
n.a. 
0.3--0.6 
n.R. 
n.a. 
1.2 
0.1-0.2 
1.2 
0.05-0.3 
2.5 
n.a. 
n.a. 
n,a. 
0.3-0.6 
n.a. 
0.3 
n.a. 
n.a., no activity as defined in text. 
* Inhibitor concentration before  dilution with  serum  and  erythrocyte  suspension.  For 
final dilution divide values by 3. 
:~ Capsular antigens listed. 
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TABLE  III* 
Bacteria with Moderate to Low Blood Group Activity 
Bacterium 
E.  COLI 
703; 12415 
10716 
3 strains 
7 strains 
16 strains 
17 strains 
1955;  14013;  Casey 
2030; 9069 
5346 
Tone IB;  14061;  K~5 
SALMONELLA 
typhi murium (2 strains~t) 
worthington 
typhi (583) 
typhi (10810) 
hvittingfoss 
urbana 
ramat-gat 
sp. 
ARIZONA 
KLEBSIELLA 
Benton 
9138 
1924; 1973; Foster (I); 
Thompson 
5192; 9597; Richardson (II) 
5276;  6173;  A.  Johnson 
(III) 
3527 
O-antigen (when known) 
4 
6 
7:Kx 
8 
lll:B, 
125 
126 
1, 4,  (5),  12 
1, 13, 23 
Minimum amount of boiled bacteria giving 
complete hemagglutination inhibition 
A1 
mg./ml. 
2.5 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
0.6-2.5 
n.a. 
n.a° 
1.2-2.5 
1.2-2.5 
2.5 
4-2.5 
n.a° 
n.a. 
mg./ml. 
H(O) 
mg./'  ml. 
n.a.  [  4-2.5 
4-2.5  i  2.5 
2.5  I  n.a. 
2.5  2.5 
1.2-+2.5  +2.5 
n.a.  1.2 
n.a.  4-4-2.5 
n.a.  n.a. 
0.6-+2.5  n.a. 
n.a.  0.6--4-2.5 
2.5  n.a. 
n.a.  1.2-2.5 
2.5  0.6 
4-2.5  4-2.5 
n.a. 
n.a. 
:t:2.5 
1.2-2.5 
9, 12 
9, 12 
16 
30 
30 
30 
25 
4-2.5 
n.a. 
4-2.5 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n,a. 
n.a. 
n.a. 
0.6 
2.5 
n°a, 
n.a. 
n.a. 
2.5 
n.a. 
1.2-2.5 
n.a. 
n.a, 
n,a. 
n.a. 
+2.5 
2.5 
-4-2.5 
1.2 
n.a. 
n.fl,. 
n.a. 
0.6-2.5 
n.a. 
0.6-2.5 
0.6-1.2 
n.a. 
n.a. 
2.5 
0.6-1.2 
0.6 
0.6--2.5 
-+-2.5 
n.a. 
-4-2.5 
n.a,. 
1.2 
n.a. 
n.a. 
n.a° 
1.2-2.5 
0.6-2.5 
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TABLE III--Continued 
Bacterium 
CITROBACTER 
1922; 8090 
1971; 9554 
2898; 5551 
8006; 8454 
5869; 6159 
4660 
O-antigen (when  known) 
Minimum amount of boiled  bacteria  giving 
complete hcmagglutlnation  inhibition 
Al  B 
mg./ml,  mg./ml. 
2.5  n.a. 
n.a.  1.2-2.5 
n.a.  II.a. 
-4-2.5  1.2-2.5 
n.a.  1.2-2.5 
2.5  n.a. 
PASTEUR.ELLA 
pseudotub~culosis 
PROTEUS 
X2 
2892; A. Johnson (IV) 
2009; 2079 
14056 
PSEUDOMONAS 
8166 
4547 
Paskall 
SERRATIA 
marcescens (9699) 
AIA2ALIGENES 
10969 
11982 
Group I 
Group H 
Group V 
n.a.  0.6-1.2 
n.a.  -4-2.5 
n.a.  1.2-2.5 
n.a.  2.5 
n.a.  1.2 
n.a.  n.a. 
n.a.  -4-2.5 
n.a.  0.6-2.5 
n.a.  n.a. 
1.2  n.a. 
n.a.  n.a. 
0.6--4-2.5 
n.a. 
n.a. 
:1:2.5 
H(O) 
mg./mL 
n.a. 
n.a. 
1.2--4-2.5 
n.a. 
2.5 
2.5 
n.a. 
n.a, 
1.2-2.5 
n,a. 
n.a. 
2.5 
4-2.5 
n.a. 
1.2 
0.6 
-4-2.5 
1.2 
0.6 
* Same footnotes as Table II. 
One strain =  var. copenhagen. 
antigen 13  (Table II). S. worthington,  which contains in addition O  antigen 1, 
was  less active  (Table III). All O  antigen 30  containing  species tested have 
similar and exclusive low H(O) activity (Table III). 
All 3  Arizona  serotypes  tested  were  active.  Arizona  031  possesses  high  B 
activity, while Arizona 09 has fairly high H(O)  activity, and Arizona 036 low 
H(O) and B  activity. 
Among the KlebsieUa tested, roughly as many organisms inhibited only one 1084  BLOOD  GROUP  ACTIVE  BACTERIA 
agglutinin  as  several  agglutinins.  One  strain  with  unknown  capsular  antigen 
showed no significantly disproportional  action. 
In  the  genus  Citrobacter,  a  rather  even  distribution  among  the  A,  B,  and 
H(O) specificities either singly or in combinations of 2 but not of all 3 activities 
was noted. 
TABLE IV 
Bacteria of Known Serotype without Blood Group Activity 
Bacterium  O-antigen 
E.  COLI 
2 strains 
SALMONELLA 
heiddberg (9787) 
enteritidis (2 strains) 
typhi (2 strains); berta 
champaign 
deversoir 
KLEBSIELLA$ 
PASTEURELLA 
pseudotuberculosis 
pestis§ (3 strains) 
I:K1 
2:K~ 
11 
26* 
55 
4, 5, 12 
1, 9, 12 
9, 12 
39 
45 
Group III 
Group IV 
* One lipopolysaccharide  preparation had moderate B activity. 
:~ Capsular type listed. 
§ One strain, Tjiwidej,  showed traces of H(O) and B activities. 
One A  active Citrobacter  and  19 E. coli were tested  against  several  immune 
and "natural" anti-A sera and against A1 and As erythrocytes. Agglutination of 
A2 erythrocytes in general was more easily inhibited by these bacterial suspen- 
sions than that of A1 erythrocytes. Not all antisera were inhibited  to the same 
extent.  Such variations were not noted in the  B- anti-B  system. 
In the genus Pasteurella,  strains  of both P. pseudotuberculosis  and P. pestis 
were tested.  In spite of all efforts the P. pseudotuberculosis  strains,  groups I-V 
(11),  often  became rough  during  culturing.  The  results  therefore  may be  an G.  F.  SPRINGER,  P.  WILLIAMSON,  AND  W.  C.  BRANDES  1085 
expression of the properties of a mixture of smooth and rough variants except 
for groups II and IV which remained smooth. Only groups I  and V exhibited 
significant activity (Table  III).  Of  the  3  different P.  pestis  strains,  2  were 
inactive in all systems tested, while 1 strain, Tjiwidej, showed traces of H(O) 
and B activity. 
Blood group  B  activity is  the  one most often found among  the  Proteuz 
strains tested; it is usually exclusive and sometimes high. 
All 3 activities were found among the Pseudomonas  strains and, except in 
one instance,  the activity was strictly disproportional. 
The  2  strains  of Serratia  marcescens  tested were  exclusively H(O)  active. 
One Bacterium anitratum was isolated from a  blood culture and showed high 
B activity only. 
A human anti-H serum and a  rabbit anti-H(O)  serum were both inhibited 
in their reaction with human O erythrocytes by S. poona at the 1 to 2.5 rag./ 
ml. level. E. coli 01~ and S. typhi murium 4685 inhibited human anti-H serum 
to a still lesser extent but not at all the rabbit anti-H(O) serum. S. atlanta was 
of low activity against rabbit anti-H(O) serum. The following bacteria showed 
borderline or no activity when tested against these 2 sera: S.  grumpensis, E. 
coli 086, S. hvittingfoss, S. urbana, and S. champaign. 
Seventy-six Enterobacteriaceae, both boiled and unboiled, were tested for 
their ability to inhibit anti-M and anti-N agglutinins, while 64 were investi- 
gated for inhibition of anti-D (Rh0) agglutinins. No bacterium gave significant 
inhibition with the exception of 1 E. coli  (14061)  which inhibited anti-D and 
anti-N, as well as anti-A, anti-B, and anti-H(O)  agglutinins, at approximately 
the same levels (1.2  to 2.5 mg./ml.). This was probably unspecific inhibition. 
DISCUSSION 
The frequent occurrence of blood group active antigens in various widely 
disseminated bacterial species is evident from the data presented here. These 
data  are  based  on  the  hemagglutination inhibition assay,  which  is  a  valid 
procedure  in  the  determination of bacterial  blood group  activity. This  has 
been shown by animal immunization, in which blood group  active bacteria 
evoked potent anti-human blood group agglutinins (5, 6, 12, 13) corresponding 
to their in vitro activities. Bacteria inactive in the hemagglutination inhibition 
test failed to stimulate anti-human blood group A, B,  or H(O)  agglutinins. 
Also,  anti-B  agglutinins  could  be  absorbed  completely  and  specifically by 
E. coli 086 as could anti-A agglutinins by an A active E. freundii and anti-H(O) 
agglutinlns by S. poona (5, 12-14). This is especially true if the bacteria exhibit 
disproportional activities, and has been confirmed by a number of investigators 
(13, 15). 
Contamination of test materials with blood group active substances from 
the medium was excluded. The broth in which all bacteria were first grown, 1086  BLOOD  GROUP  ACTIVE  BACTERIA 
after being picked from a slant, contained considerable amounts of A and H(O) 
(but  not  B,  M,  N,  or  D  (Rh0))  active material.  However,  the  subsequent 
9 daily transfers with a wire loop, from one tube of fully defined medium to the 
next,  dilute out blood group  active material.  No  blood group  activity was 
demonstrated in the first tube with fully defined medium, into which transfer 
had been made from the broth culture. 
False negative results arising from agglutination of erythrocytes by bacteria 
alone were excluded in the following manner: a  cross-section of 33  bacterial 
suspensions was incubated in different experiments with 4 hemagglutinating 
doses of anti-H(O) eel serum and a 1:15 dilution of serum from an A1B person. 
After 90 minutes a 0.5 per cent suspension of an A1, B, and O red cell mixture 
was added to the human serum and of A1B cells to the eel serum. There was no 
erythrocyte agglutination by any sample. 
Mter our report  (4,  5)  on the high blood group B  activity of E.  coli  0Be, 
Iseki,  Onuki,  and  Kashiwagi  (13)  pointed  out  the  established  serological 
relationship between E. coli 086, Arizona 021, and Salmonella having 0  antigen 
43  (8,  16)  and  showed  by  absorption  and  immunization experiments  that 
Arizona 021 and S. milwaukee possess  blood group B active antigens similar to 
E. coil  0Be. The results of our hemagglutination inhibition experiments with 
Arizona  0~1 and S.  berkeley  (containing the Salmonella  0  antigen 43)  are in 
agreement with the findings of the Japanese investigators. The absence of any 
H(O) activity from Arizona 021 and S. berkeley points to a difference between 
the antigens of these bacteria and those of E. coli O86:B7 and Bg, which fre- 
quently showed slight H(O) activity. 
Although Arizona  09  and E.  coli  O55:B5 cross-react  with their respective 
antisera  (8),  Arizona  09  shows  significant blood group  activity but  E.  coli 
O55:B5 does not. 
Association of H(O)  antigen with group antigen 13  of Salmonella  appears 
to be established by earlier observations on 1 strain each of S. poona  and S. 
worthington  (2,  4)  and by the present finding of exclusive H(O)  activity for 
all strains of S.  poona,  S.  grumpensis,  S.  atlanta,  and S.  worthington  tested. 
The first 3 of these species  are of equal, rather high activity. They possess,  in 
addition to antigen 13, antigen 22 or 23 but not antigen 1. S. worthington,  on 
the other hand, possessing O antigens 1,  13, and 23, is of low activity (Tables 
II and III). O antigen 1 therefore may interfere with the combination of the 
anti-H(O) agglutinin with its complementary grouping on the bacterial surface. 
Bacteria which inhibited the agglutination of O erythrocytes by eel serum 
were  tested with human and rabbit  anti-H(O)  sera.  By this selection other 
active  bacteria  may have  been  omitted.  Only  some  of  the  bacteria  which 
inhibited eel sera were active against human and rabbit anti-H, and then to 
a lesser extent than against eel serum. 
Chemical investigations, notably those of Morgan and Kabat (cf. references G.  F.  SPRINGER,  P.  WILLIA~SON,  AND  W.  C.  BRANDES  1087 
17-19),  have led to the elucidation of portions of the essential chemical struc- 
tures  responsible  for  the  serological  specificity of  the  human  blood  group 
mucoids.  The  identical  monosaccharides,  namely  D-galactose,  T.-fucose, N- 
acetyl-D-glucosamine,  and N-acetyl-D-galactosamine  are present in A, B, and 
H(O) substances. The evidence obtained indicates that the specificity of these 
mucopolysaccharides resides  in  their  carbohydrate portion  and  is associated 
with oligosaccharide  units. The terminal,  non-reducing monosaccharides most 
responsible  for serological specificity  of each blood group substance appear to 
be: N-acetyl-D-galactosamine for A substance, D-galactose for B, and L-fucose 
for H(O) (cf. references  18, 19). 
E. coli 
Highly Blood C-ton 
Bacterium 
S. poona 
S. grnrapensis 
S. atlanta 
S. berkeley 
Arizona 
TABLE  V 
# Active Bacteria with Known O-Antigen  Carbohydrates 
O-antigen  Specificity 
86 
127 
128 
13, 22 
13, 23 
13, 23 
43 
9 
21 
Sugars  shared  with human blood 
group  mucoids 
B 
H(O) 
H(O) 
H(O) 
H(O) 
H(O) 
B 
H(O) 
B 
~)  =  Sugar responsible for most of a  given activity 
references see text. 
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+  + 
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blood group mucoids. For 
Analyses of the polysaccharide antigens of various Gram-negative bacteria 
by chromatography and on occasion by classical chemical methods (11, 20-32) 
have given evidence for the presence of carbohydrate building-stones identical 
with those of the blood group mucoids. To account for closely related serological 
specificity,  blood group active organisms  would be expected to possess chemical 
groups corresponding  in nature, structure, and orientation to those present in 
the human blood group mucoids. This was shown to be probable for the blood 
group active polysaccharide complex of E. coli O86:B~ (29). 
General agreement was found between the nature  of known carbohydrate 
building-stones (24, 29-32) and the observed blood group activity of the investi- 
gated bacteria (Table V). In all  cases in which the activity was moderate to 
high,  the H(O)  active  bacteria  contain  fucose,  A  active  bacteria  N-acetyl- 
galactosamine,  and B active bacteria galactose.  It is  noteworthy that  fucose 1088  BLOOD GROUP ACTIVE BACTERIA 
was found in all O antigens of the chemically investigated highly active bacteria 
(Table V), whereas bacteria may have low blood group activity but lack this 
sugar, e.g.E,  coli 06 and 2 strains of S. typhi (24, 31). 
The presence of all 4 sugars of human blood group mucoids has been reported 
(24, 29-32) for the O antigens of those bacteria listed in Tables V and VI, with 
the exception of Arizona  09,  which lacks galactosamine. It should be stressed 
that  glucosamine is  a  constituent of the lipid part  of the lipopolysaccharide 
and not necessarily a  component of the polysaccharide as well  (11,  22).  No 
active bacterium contained less  than  2  of the  sugars  found in human  blood 
group substances. In all instances in which the specific sugar was not detected 
in the O antigen, activity observed was weak. 
TABLE VI 
Bacteria with Low or No Blood Group Activity Possessing All Sugars of Blood Group Mucoids 
Bacterium  O-antigen 
E. coil 
S. worthington 
S. hvittingfoss 
S. urbana 
S. ramat-gat 
S. champaign 
Arizona 
11 
125 
1, 13, 23 
16 
30 
30 
39 
25 
For references  see text. 
The frequently noted B specificity of Proteus strains is in agreement with the 
presence of galactose in a Proteus 0X19 polysaccharide. Among the other sugars 
identified  (27),  only N-acetylglucosamine is  a  component  of  human  blood 
group mucoids. 
The absence of activity in the 5 strains of Sh. flexneri tested is understand- 
able, as the only sugar present in both the O  antigen of this bacterium and 
blood group mucoids is glucosamine (21). 
The lipopolysaccharides of P. pestis Tjiwidej and of 2 other P. pestis strains 
have been isolated and characterized by Davies (28). He found only glucose, 
glucosamine,  and  an  unidentified  aldoheptose as  component  carbohydrates. 
We observed a  trace of H(O) and B  activity for the whole Tjiwidej organism 
and no blood group activity for the 2 other strains. 
While so far significant activity in bacteria has not been observed when the 
monosaccharide responsible for the major part of a  given activity in human 
blood group mucoids was stated to be missing in the O antigen, the converse 
is not necessarily the case. In addition to those listed in Table VI, S. deversoir, 
E. coli 055, and E.  coli  O1~6 have  been reported  (30,  31)  to  contain  at  least 
3  sugars  of  the  human  blood  group  mucoids;  nevertheless,  these  bacteria G.  F.  SPRINGER,  P.  WILLIAMSON,  AND  W.  C.  BRANDES  1089 
were either inactive or possessed low activity only. Also, otherwise highly active 
fucose-containing  strains such as S.  berkeley, Arizona 0~1, and E.  coli Ose:B~ 
show no or only borderline H(O)  activity. 
Assuming a  similar proportion of blood group constituent monosaccharides 
in blood group active bacteria and in those without activity, one would expect 
that in the latter group the monosaccharides  in question are either linked in 
sequence and orientation in such a way as to render them inaccessible to the 
antibody or that they are present as the enantiomorphous isomer of the active 
form. It is generally accepted that only one member of a pair of enantiomorphs 
is significantly active in a given immunological system (33). It may be predicted 
therefore that all highly H(O) active bacteria (in the eel serum system) contain 
L-fucopyranoside in a-glycosidic linkage, all highly B active bacteria a terminal 
a-9-galactosyl structure, while an a-N-acetyl-~galactosaminoyl  structure most 
likely is responsible for the activity of A specific bacteria. Other sugars struc- 
turally related to the parent  compound may also play a  role  in low blood 
group activity, as has been shown for compounds  closely related structurally 
to L-fucose (34, 35). Thus, the low H(O) activity of E. coli Om may be explained 
by its content of properly integrated 3-deoxy-L-fucose, although this sugar is 
inactive as a monosaccharide  (34). On the other hand, E. coli 055 which also 
contains 3-deoxy-L-fucose (31) possesses no H(O) activity. 
Attempts to correlate  the blood group activities of bacteria with the chem- 
istry of their O antigens have to take into account that drastic procedures 
have been  employed (22, 24)  in  the  isolation  of almost all  the O  antigens 
analyzed for carbohydrate components.  It may be relevant that more highly 
B active material was obtained from E. coli O86:B~ (29) by a mild extraction 
method (50 per cent aqueous pyridine, at 37°C. (21)) than with hot 45  per 
cent aqueous phenol. 
Few of the more  recent chemical  studies  of Gram-negative  bacteria have 
considered  the  K  antigens  which  presumably  are  carbohydrate  but  more 
labile  than  the  O  antigens  (8,  36). Most  of  our  bacterial  suspensions 
contained K antigens, probably in solution. Unremoved K antigens may mask 
blood group active O antigens as seems likely for the colominic acid-containing 
bacterium E.  coli 07:1(1 which inhibits blood group  B  agglutinins  only after 
heating on a boiling water bath. 
On the other hand, K antigens may contribute to the blood group activities 
observed and may help explain the borderline H(O) activity of the 2 strains of 
S.  typhi  murium.  These  bacteria belong  to Salmonella  group B  in whose O 
antigens no fucose or galactosamine  has been  found. Another Salmonella  B, 
S.  heidelberg, did  not  possess demonstrable  H(O)  activity.  Similarly,  of  6 
strains of Salmonella  group D1,  which reportedly contain no galactosamine,  1 
S. typhi showed low A activity, while the  remaining  5 Salmonella  D1 did not 
possess A specificity. 
The trace of blood group activity found in 1 of 3 strains of P. pestis cannot 1090  BLOOD GROUP ACTIVE BACTERIA 
be explained on the basis of the reported chemistry (28)  of the O  antigen of 
this strain. 
In the Klebsiella, capsular and somatic antigens  may both contribute to the 
hemagglutination  inhibitions  observed,  since  the  capsules  are  removed from 
the bacterial surfaces by heating on a boiling water bath but are not destroyed 
(26).  Fucose, glucose, uronic acid,  and in some instances galactose have been 
shown  (25,  26)  to  be present  in  capsular polysaccharide preparations  of the 
Klebsiella.  The  presence  of  galactose  has  been  attributed  to  contamination 
with somatic material (26).  There appears to be no detailed knowledge of the 
chemical nature of this genus' somatic antigens. 
The most active whole B  specific bacteria, E.  coli 086, Arizona  021, and S. 
berkeley approximate, in  the hemagglutination  inhibition  test,  the  activity of 
crude  human  blood  group  B  substance  preparations  obtained  from pseudo- 
mucinous ovarian cysts and meconium (4,  9). 1 The most highly H(O)  active 
bacterium,  E.  coli  Ore,  has  an  activity  similar  to  H(O)  mucoids  of human 
origin.  No A  specific bacterium was this active. It is remarkable, even if an 
anamnestic response is considered,  that anti-human A agglutinins obtained in 
rabbits with  a  moderately A  active E. freundii  were  somewhat more potent 
than anti-B  agglutinins obtained at the same time with E.  coli O86:B7 under 
identical  conditions  (5,  14). 
No marked disproportional  activity was  noted  for  1  Klebsiella  and  a  few 
E. coli  strains  (Tables  II and  III). In  these  instances,  unspecific  inhibition 
such as that given by some strongly acidic polymers must be excluded before 
assuming that these bacteria possess substances with similar A, B, and H(O) 
specificity. 
The lack of significant disproportional inhibition of the anti-M, anti-N, and 
anti-D  (Rho) agglutinins by the bacteria tested is noteworthy and compatible 
with  the rare occurrence of these  agglutinins  without  deliberate stimulation. 
Four inactive bacteria, obtained from Dr. W. F. Goebel and Dr. G. T. Barry, 
are known to contain colominic acid (cf. reference 36), a polymer of sialic acid 
which is a  component of M  and N  specific substances (10,  37,  38). 2 
x In the quantitative assay highly purified B active material from E. coli Os6:  Br precipitated 
in  the  equivalence zone of  an homologous human  blood group  B  mucoid-hyperimmune 
anti-B  serum  system  approximately one-half as  much  antibody  as  did  the  B  mucoid. 
Furthermore, agar-gel diffusion studies showed a fusion line between human  B mucoid and 
E. coli 086 polysaccharide  complex (Springer, G. F., and Readier, B., data to be published). 
2 This lack of specific  inhibition of anti-D (Rho), anti-M, and anti-N is in agreement with 
our observations (unpublished) that N-acetyl- and  N-glycolylneuraminic acids, colominic 
acid, crystallized brain gangliosides, and  numerous derivatives of sialic acid did not inhibit 
anti-M, anti-N, or anti-D (Rho) agglutinins under the conditions of our test. Our observations 
on anti-D (Rho) agglutinins are in contrast to a recent report (Dodd, M. C., Bigley, N. J., 
and Geyer, V. B., Specific inhibition of Rho (D) antibody by sialic acids, Science, 1960, 132, 
1398). G.  ~'.  SPRINGER,  P.  WILLIAMSON,  AND  W.  C.  BRANDES  1091 
Of the few Gram-positive bacteria which have been tested, none has shown 
A, B, or H(O) activity (4, 7). 
Our studies of blood group activity in bacteria show that A,  B, and H(O) 
activity is  not  confined to  any particular genus  of  Gram-negative bacteria. 
It is noteworthy therefore that the antigens of blood group active Salmonella 
also occur in other bacteria. Saphra and Silberberg (39) reported on 13 coliform 
strains which possessed the O antigens of the S. worthington-S, poona group in 
various  combinations.  Similarly  Wheeler,  Stuart,  Rustigian,  and  Borman 
(40) found Klebsidla and Escherichia  strains, as well as other coliform organ- 
isms, to possess various Salmonella 0  antigens. 
SUMMARY 
Distribution of blood group A,  B, and H(O)  activities among  282  aerobic 
Gram-negative bacteria, many isolated from the blood of patients,  has  been 
studied.  Almost half of these bacteria were found to be blood group active. 
About 10 per cent of the organisms exhibited high, disproportional activities, 
which in some instances approached those of crude human blood group mucoids. 
No significant, specific D  (Rho), M, or N  activity was found in approximately 
70 members of the Enterobacteriaceae. 
An attempt was made to correlate the observed activity of a given organism 
of known O somatic antigen with its monosaccharide components. The presence 
of those sugars which account for the specificity of human blood group mucoids 
was noted. 
The bearing of  these  findings  on the  origin of human  anti-A  and  anti-B 
isoantibodies has been mentioned. 
The authors are grateful to Dr. C. M. MacLeod, Dr. E. A. Kabat, Dr. P.  R.  Edwards, 
and Dr. H. M. Rawnsley  for their kindness in reading and criticizing  the manuscript. 
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the bacteria, to Dr. P. Levine, Raritan, New Jersey, for a human anti-H serum (Helen Por- 
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